secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anteris Technologies Global Corp. (AVR)
CIK:        0002011514
Form:       8-K
Filed at:   2026-01-22T23:59:59+00:00
Accession:  0001140361-26-001938
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anteris raises ~$320M via public offering and Medtronic PIPE for DurAVR THV trial
--------------------------------------------------------------------------------

- Public offering of 40M shares at $5.75 (including full over-allotment); gross proceeds ~$230M.
- Medtronic subsidiary invests $90M via PIPE at same $5.75 price; gets board observer and participation rights.
- Proceeds to fund PARADIGM pivotal trial of DurAVR THV, expand manufacturing, and v2vmedtech R&D.
- Offering and PIPE expected to close Jan 22, 2026; officers/directors subject to 90-day lock-up.
- Medtronic's shares subject to transfer restrictions until May 2027 and volume limits through Jan 2029.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2011514/000114036126001938/0001140361-26-001938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2011514/000114036126001938/ny20062007x7_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-001938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer